Improving Hepatitis A and B Vaccinations and Screenings in an Outpatient GI Setting

Abstract

Hepatitis A (HAV) and B (HBV) are highly transmittable, vaccine-preventable infections that can cause chronic infection, increased risk for hepatocellular carcinoma, and cirrhosis. Individuals with chronic liver disease are at an increased risk for developing these complications if infected with either condition. Current national guidelines recommend HAV and HBV screening and vaccination for all individuals with chronic liver disease. Research shows that approximately half of the patients with chronic liver disease are not adequately screened for and vaccinated against HAV and HBV despite these recommendations. A quality improvement project utilizing the Plan Do Study Act (PDSA) cycle was performed in an outpatient gastroenterology clinic setting with the intent of increasing HAV and HBV screenings and vaccinations in patients with chronic liver disease. Components from the 4 Pillars Practice Transformation Program framework, which utilizes evidence-based research to improve vaccination uptake in outpatient settings, were also applied.